Morningstar

Botox Makes Allergan Worth a Shot

The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...
Orange County Business Journal

Botox, Medical Cosmetics Boost Allergan’s Profits

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...
Orange County Business Journal

Allergan Jumps on Botox Approval for Migraines

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...
Reuters

Allergan says Botox works on chronic migraines

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...
Nasdaq

Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China

BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...
Seeking Alpha

Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands

Consumers Can Apply for a Chance to Be Featured in Upcoming Campaigns for BOTOX ® Cosmetic, the JUVÉDERM ® Collection of Fillers, and Allē, the Allergan Aesthetics Loyalty Rewards Program "We are ...
Seeking Alpha

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

"At my practice, we leverage Allē to ensure BOTOX ® Cosmetic Day is successful for patients looking to explore the results that can be achieved with BOTOX ® Cosmetic," said Dr. David Shafer, double ...
Nasdaq

Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...
Reuters

Allergan jumps as Botox migraine OK seems closer

NEW YORK (Reuters) - Regulators seem inclined to approve Allergan Inc's wrinkle drug Botox to prevent migraine headaches in millions of Americans, industry analysts said, based on information the ...
Yahoo

Botox Is More Affordable Than Ever. Is That A Good Thing?

Add Yahoo as a preferred source to see more of our stories on Google. And with mass appeal comes mass pricing. On social media, some aestheticians are offering Botox for as little as $7 a unit. Search ...
Los Angeles Times

Allergan’s profit falls on promotional costs

Allergan Inc., maker of the wrinkle smoother Botox, said fourth-quarter profit fell 2.4% on spending to promote new products including breast implants and a skin-filling gel. Allergan’s net income ...